Edward Hines Jr. VA Hospital in suburban Chicago has started enrolling its first veterans in a federally authorized psilocybin-assisted therapy clinical trial for treatment-resistant PTSD. The study pairs supervised, high-dose psilocybin sessions with structured preparatory and integrative psychotherapy and will follow participants for 12 months. For many local veterans who have not improved on standard therapies, the trial offers a tightly monitored, clinic-only option, not a backdoor to recreational use.
As first reported by Medical Daily, Hines is joining VA sites in Houston, New York, and San Francisco that are testing psychedelic-assisted protocols. The rollout accelerated after President Donald Trump signed an April 18 executive order directing federal agencies to speed research and expand pathways for certain psychedelic compounds, according to AP.
How the Hines study works
The Hines protocol follows the three-phase model now common in psilocybin research: preparatory psychotherapy, one or two supervised high-dose dosing sessions in a controlled clinical room, and integration therapy afterward, with outcomes tracked for a year. That structured "set and setting" approach is the same framework used in trials run by institutions such as Johns Hopkins and NYU. A 2024 meta-analysis found that roughly 30 to 40 percent of patients with PTSD fail to respond adequately to first-line psychological treatments, which is why researchers have prioritized trials focused on treatment-resistant cases (NCBI).
Why researchers are watching
Late-stage clinical data have sharpened scientific interest in psychedelic approaches. Compass Pathways reported positive Phase-3 results for its synthetic psilocybin program in February 2026, showing rapid and durable benefit in treatment-resistant depression, and MAPS' MDMA work has produced large effect sizes in PTSD studies, findings that have helped prompt federally supported veteran research (STAT). The VA has also moved forward on MDMA trials, reflecting broader agency support for carefully regulated, evidence-driven studies (U.S. Department of Veterans Affairs).
Chicago's need and who could benefit
Edward Hines Jr. is one of the VA's largest hospitals in the Midwest and treats more than 56,000 veterans, according to VA Hines health care. Local planning documents estimate Cook County's veteran population at over 100,000, with many veterans living in neighborhoods that bear a heavy burden of violence and limited access to specialty mental-health care (Cook County CHNA).
Who can enroll and safety protections
Eligibility requires a PTSD diagnosis and previous attempts with at least two evidence-based modalities, and prospective participants undergo medical screening to exclude contraindications, Medical Daily reports. Administration is clinic-only and supervised by trained clinicians. These trials explicitly prohibit at-home or recreational use and build in multiple safety checks consistent with Johns Hopkins-style protocols (ClinicalTrials.gov).
What’s next
Researchers will follow participants for 12 months and publish safety and efficacy findings that could influence whether psychedelic-assisted therapies are adopted more widely within the VA. Veterans seeking details about the Hines study or other VA research opportunities are directed to contact the Hines VA Mental Health Research program or visit the VA Hines research pages for updates (VA Hines health care). Experts stress that these treatments remain experimental and tightly regulated (StatPearls).
